Causal effect of anxiety and depression status on the symptoms of gastroesophageal reflux disease and functional dyspepsia during proton pump inhibitor therapy

被引:0
|
作者
Koji Nakada
Atsushi Oshio
Nobuyuki Matsuhashi
Katsuhiko Iwakiri
Takeshi Kamiya
Noriaki Manabe
Takashi Joh
Kazuhide Higuchi
Ken Haruma
机构
[1] The Jikei University School of Medicine,Department of Laboratory Medicine
[2] Waseda University,Faculty of Letters, Arts and Sciences
[3] NTT Medical Center,Department of Gastroenterology
[4] Nippon Medical School Graduate School of Medicine,Department of Gastroenterology
[5] Nagoya City University Graduate School Medical Sciences,Department of Medical Innovation
[6] Kawasaki Medical School,Division of Endoscopy and Ultrasonography, Department of Clinical Pathology and Laboratory Medicine
[7] Gamagori City Hospital,Second Department of Internal Medicine
[8] Osaka Medical and Pharmaceutical University,Department of General Internal Medicine 2
[9] Kawasaki Medical School Kawasaki Hospital,undefined
来源
Esophagus | 2023年 / 20卷
关键词
Gastroesophageal reflux disease; Dyspepsia; Anxiety; Depression; Causal relationship;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:309 / 316
页数:7
相关论文
共 50 条
  • [21] More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy
    Kusano, Motoyasu
    Hosaka, Hiroko
    Kawamura, Osamu
    Kawada, Akiyo
    Kuribayashi, Shiko
    Shimoyama, Yasuyuki
    Yasuoka, Hidetoshi
    Mizuide, Masafumi
    Tomizawa, Taku
    Sagawa, Toshihiko
    Sato, Ken
    Yamada, Masanobu
    JOURNAL OF GASTROENTEROLOGY, 2015, 50 (03) : 298 - 304
  • [22] More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy
    Motoyasu Kusano
    Hiroko Hosaka
    Osamu Kawamura
    Akiyo Kawada
    Shiko Kuribayashi
    Yasuyuki Shimoyama
    Hidetoshi Yasuoka
    Masafumi Mizuide
    Taku Tomizawa
    Toshihiko Sagawa
    Ken Sato
    Masanobu Yamada
    Journal of Gastroenterology, 2015, 50 : 298 - 304
  • [23] Gastroesophageal reflux disease in primary care: Using changes in proton pump inhibitor therapy as an indicator of partial response
    Ruigomez, Ana
    Johansson, Saga
    Wernersson, Boerje
    Fernandez Cantero, Oscar
    Garcia Rodriguez, Luis A.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (07) : 751 - 761
  • [24] Comparison of Daily versus Weekly Recording of Gastroesophageal Reflux Disease Symptoms in Patients with a Partial Response to Proton Pump Inhibitor Therapy
    Ryden, Anna
    Leavy, Olivia C.
    Halling, Katarina
    Stone, Arthur A.
    VALUE IN HEALTH, 2016, 19 (06) : 829 - 833
  • [25] Effect of potassium competitive acid blocker compared to proton pump inhibitor in gastroesophageal reflux disease
    Wepee, Roderick, Jr.
    Te, Marilyn
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 278 - 278
  • [26] Impact of dialysis on gastroesophageal reflux, dyspepsia, and proton pump inhibitor treatment in patients with chronic renal failure
    Strid, Hans
    Fjell, Andreas
    Simren, Magnus
    Bjornsson, Einar S.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (02) : 137 - 142
  • [27] The efficacy and safety of itopride as an add-on therapy to a proton pump inhibitor in the treatment of gastroesophageal reflux disease
    Wasko-Czopnik, Dorota
    Wiatrak, Benita
    GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2024, 19 (01): : 60 - 66
  • [28] Effects of rikkunshito on quality of life in patients with gastroesophageal reflux disease refractory to proton pump inhibitor therapy
    Kawai, Takashi
    Hirayama, Yoji
    Oguchi, Aiko
    Ishii, Fumi
    Matushita, Masanao
    Kitayama, Naoya
    Morishita, Shinji
    Hiratsuka, Noboru
    Ohata, Ken
    Konishi, Hiroyuki
    Kishino, Maiko
    Nakamura, Shinichi
    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2017, 60 (02) : 143 - 145
  • [29] Low levels of adherence with proton pump inhibitor therapy contribute to therapeutic failure in gastroesophageal reflux disease
    Dal-Paz, K.
    Moraes-Filho, J. P.
    Navarro-Rodriguez, T.
    Eisig, J. N.
    Barbuti, R.
    Quigley, E. M. M.
    DISEASES OF THE ESOPHAGUS, 2012, 25 (02) : 107 - 113
  • [30] Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions
    Mermelstein, Joseph
    Mermelstein, Alanna Chait
    Chait, Maxwell M.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2018, 11 : 119 - 134